Alembic Pharmaceuticals has secured a key USFDA approval for its generic Methotrexate injection, marking another step in its expansion in the United States market. The approval, granted by the US Food and Drug Administration, allows the company...
A groundbreaking study published in the journal Nature has provided the strongest evidence yet that acquired (somatic) DNA mutations in immune cells may be a key driver of autoimmune diseases. Researchers from the Wellcome Sanger Institute, Univer...
A new study has raised concerns about how reliable AI chatbots are when it comes to providing medical information. The research found that many of their responses can be inaccurate medical advice or incomplete, which could mislead users seekin...
India has taken an important step in global health collaboration by chairing the first BRICS Health Working Group (HWG) meeting for 2026. The meeting, held in New Delhi, brought together health officials and experts from member countries to discus...
India’s radiotherapy device market is entering a high-growth phase, driven by a sharp rise in cancer cases, expanding healthcare infrastructure, and increased public investment in oncology care. Industry estimates indicate the market could more...
Novo Nordisk’s weight loss drug has shown promising liver benefits in a new preclinical study, pointing to effects beyond just shedding pounds. Researchers found that the company’s GLP-1-based treatment improved liver health in mice, even when...
As India’s biotechnology sector enters a high-growth phase, a key question is emerging: can it deliver breakthrough therapies globally? In the latest episode of the “What India Needs!” podcast, host Shutapa Paul spoke with Dr Jogin Desai, Found...
MSN Laboratories launches Semabest, a semaglutide drug priced 50% lower in India, boosting access to advanced diabetes treatment for millions.
The US Food and Drug Administration has asked Eli Lilly to submit additional safety data for its newly approved weight-loss pill, Foundayo, even as the drug begins entering the market.
India’s homeopathy industry is seeing a steady rise in global demand, supported by the government’s push to improve quality standards through the AYUSH Premium Mark initiative. Experts believe this move is helping build trust in Made in Indi...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")